How scientists measure aging through Healthspan, frailty and quality of life
Our Healthspan study results have been published in GeroScience. Let’s dive into the results.
At Loyal we’re developing the first FDA-approved drugs explicitly intended to extend lifespan and healthspan, and being first means charting new waters.
On the path to FDA approval, we must run a clinical trial that objectively and robustly demonstrates that our drug extends dogs’ healthy lifespan, and does so safely. Because no one has developed a dog — or human — longevity drug before, we are building the path to FDA approval largely from scratch.
Last week we learned from the FDA that Loyal received protocol concurrence for our companion dog longevity study — likely the first time the FDA has given their blessing to a longevity clinical trial. Our regulatory expert Karen Greenwood weighs in on what this means for Loyal, for the field of aging, and for dogs everywhere.
Our Healthspan study results have been published in GeroScience. Let’s dive into the results.
Dogs come in an astounding range of shapes and sizes. Explore how genetic differences impact age and how Loyal is working on extending the lives and health of large dogs.
One of the most important health problems in veterinary medicine today is the epidemic of obesity in our pets.
Lifespan is the amount of time lived. Healthspan is the time lived with vigor and good health. Which do you think is more important?
Dogs age a lot like humans, though sadly much faster. Helping us to better understand our own aging is just one of the many gifts our canine best friends give us.
Like death and taxes, aging has long been seen as unavoidable. Science is now showing us that this may not be true.
There are many theories about how aging works. Lat’s take a brief look at two: Wear & Tear and the Rate of Living.
If evolution means survival of the fittest, shouldn’t animals evolve to stay healthy and live forever? Unfortunately, the evolutionary race goes to the most fertile, not the most enduring.